News

Select Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
April 20, 2020 6:05 AM
EDT
2020
Aurinia Appoints Industry Veteran Timothy P. Walbert to its Board of Directors
Download
March 18, 2020 6:05 AM
EDT
2020
Aurinia Announces AURORA Phase 3 Clinical Data for Voclosporin in Lupus Nephritis to be Presented at National Kidney Foundation 2020 Spring Clinical Meetings
Download
March 17, 2020 6:00 AM
EDT
2020
Aurinia Pharmaceuticals Establishes U.S. Commercial Operations Center in Rockville, Maryland
Download
March 16, 2020 6:05 AM
EDT
2020
Aurinia Pharmaceuticals Initiates Rolling Submission of a New Drug Application to the U.S. Food and Drug Administration for Voclosporin in the Treatment of Lupus Nephritis
Download
March 12, 2020 7:00 AM
EDT
2020
Aurinia Launches Resource Kit for People Living With Lupus Nephritis and Partners With National Kidney Foundation on Awareness Initiative
Download
March 5, 2020 4:02 PM
EST
2020
Aurinia Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Highlights
Download
March 3, 2020 6:30 AM
EST
2020
Aurinia Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results on March 5, 2020
Download
February 25, 2020 6:30 AM
EST
2020
Aurinia Appoints Max Colao as Chief Commercial Officer and Expands U.S. Commercial Leadership Team
Download
February 21, 2020 4:05 PM
EST
2020
Aurinia Pharmaceuticals to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Download
December 12, 2019 9:26 AM
EST
2019
Aurinia Closes US$191.7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares
Download
December 9, 2019 9:00 PM
EDT
2019
Aurinia Prices US$166.7 Million Public Offering of Common Shares
Download
December 4, 2019 4:05 PM
EST
2019
Aurinia Announces Positive AURORA Phase 3 Trial Results Demonstrating Voclosporin Superiority Over Standard of Care in Lupus Nephritis
Download
December 3, 2019 6:30 AM
EST
2019
Aurinia to Present Preclinical Voclosporin Data at 2020 Keystone Symposia Conference
Download
November 14, 2019 4:02 PM
EST
2019
Aurinia Reports Third Quarter 2019 Financial Results and Recent Operational Highlights
Download
November 13, 2019 4:05 PM
EST
2019
Aurinia Announces Updates to the Board of Directors
Download
November 7, 2019 6:30 AM
EST
2019
Aurinia Completes Voclosporin Drug-Drug Interaction Study Demonstrating No Clinically Significant Interaction With Mycophenolate Mofetil
Download
November 6, 2019 4:05 PM
EST
2019
Aurinia Pharmaceuticals to Release Third Quarter 2019 Financial Results on November 14, 2019
Download
August 6, 2019 4:02 PM
EDT
2019
Aurinia Reports Second Quarter 2019 Financial Results and Operational Highlights
Download
May 14, 2019 4:02 PM
EDT
2019
Aurinia Reports First Quarter 2019 Financial Results and Recent Operational Highlights
Download
March 19, 2019 4:02 PM
EDT
2019
Aurinia Reports Fourth Quarter and Full Year 2018 Financial Results and Operational Highlights
Download
November 8, 2018 4:02 PM
EST
2018
Aurinia Reports Third Quarter Financial Results, Clinical Highlights and Corporate Development
Download
August 9, 2018 4:02 PM
EDT
2018
Aurinia Reports Second Quarter Financial Results and Operational Highlights
Download
May 10, 2018 4:02 PM
EDT
2018
Aurinia Reports First Quarter Financial Results and Operational Highlights
Download
March 15, 2018 4:02 PM
EDT
2018
Aurinia Reports Fourth Quarter and Full Year 2017 Financial Results and Operational Highlights
Download
No Results Found
Please try different keywords or filters.

Email Alerts

By providing your email address above, you are providing consent to Aurinia Pharmaceuticals Inc. to send you the requested Investor Email Alert updates. For information on how we protect your information, please refer to our Privacy Policy.
Thank you! Your message has been sent!
Oops! There was an error with your submission.